Page last updated: 2024-10-22

amifostine anhydrous and Ascites

amifostine anhydrous has been researched along with Ascites in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Ascites: Accumulation or retention of free fluid within the peritoneal cavity.

Research Excerpts

ExcerptRelevanceReference
" Both amifostine and WR 1065 were rapidly cleared from the plasma (95% and 50% of the peak concentration within 1 h, respectively)."1.29Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient. ( Gall, HE; Korst, AE; van der Vijgh, WJ; Vermorken, JB, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korst, AE1
Gall, HE1
Vermorken, JB1
van der Vijgh, WJ1

Other Studies

1 other study available for amifostine anhydrous and Ascites

ArticleYear
Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.
    Cancer chemotherapy and pharmacology, 1996, Volume: 39, Issue:1-2

    Topics: Adenocarcinoma; Amifostine; Ascites; Chromatography, High Pressure Liquid; Disulfides; Half-Life; Hu

1996